Search Results - A. Autio
- Showing 1 - 12 results of 12
-
1
External and internal drivers behind the formation, vegetation succession, and carbon balance of a subarctic fen margin by T. Juselius-Rajamäki, S. Piilo, S. Salminen-Paatero, E. Tuomaala, T. Virtanen, A. Korhola, A. Autio, H. Marttila, P. Ala-Aho, A. Lohila, A. Lohila, M. Väliranta
Published in Biogeosciences (2025-07-01)Get full text
Article -
2
Mapping vascular network architecture in primate brain using ferumoxytol-weighted laminar MRI by Joonas A Autio, Ikko Kimura, Takayuki Ose, Yuki Matsumoto, Masahiro Ohno, Yuta Urushibata, Takuro Ikeda, Matthew F Glasser, David C van Essen, Takuya Hayashi
Published in eLife (2025-06-01)Get full text
Article -
3
The nonhuman primate neuroimaging and neuroanatomy project by Takuya Hayashi, Yujie Hou, Matthew F Glasser, Joonas A Autio, Kenneth Knoblauch, Miho Inoue-Murayama, Tim Coalson, Essa Yacoub, Stephen Smith, Henry Kennedy, David C Van Essen
Published in NeuroImage (2021-04-01)Get full text
Article -
4
Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer by Karen A. Autio, Deaglan J. McHugh, Dana E. Rathkopf, Han Xiao, Swathi Merugu, Phillip Wong, Mehrin Jan, Tanya B. Dorff, Elisabeth I. Heath, Howard I. Scher
Published in Journal of Immunotherapy and Precision Oncology (2025-04-01)Get full text
Article -
5
Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer by Daniel Vargas P. de Almeida, Justine M. Anderson, Daniel C. Danila, Michael J. Morris, Susan F. Slovin, Wassim Abida, Erica D. Cohn, Raymond E. Baser, Howard I. Scher, Karen A. Autio
Published in Journal of Immunotherapy and Precision Oncology (2023-11-01)Get full text
Article -
6
Empirical transmit field bias correction of T1w/T2w myelin maps by Matthew F. Glasser, Timothy S. Coalson, Michael P. Harms, Junqian Xu, Graham L. Baum, Joonas A. Autio, Edward J. Auerbach, Douglas N. Greve, Essa Yacoub, David C. Van Essen, Nicholas A. Bock, Takuya Hayashi
Published in NeuroImage (2022-09-01)Get full text
Article -
7
CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study by Omid Hamid, Fiona Thistlethwaite, Johanna Bendell, Ruth Plummer, Patrick A Ott, Rachel E Sanborn, Karen A Autio, Valentina Boni, Elisabeth GE de Vries, Javier Garcia-Corbacho, Daniel C Cho, Mark Stroh, Lawrence Lu
Published in Journal for ImmunoTherapy of Cancer (2021-07-01)Get full text
Article -
8
What conditions favor the influence of seasonally frozen ground on hydrological partitioning? A systematic review by P Ala-Aho, A Autio, J Bhattacharjee, E Isokangas, K Kujala, H Marttila, M Menberu, L-J Meriö, H Postila, A Rauhala, A-K Ronkanen, P M Rossi, M Saari, A Torabi Haghighi, B Kløve
Published in Environmental Research Letters (2021-01-01)Get full text
Article -
9
Towards HCP-Style macaque connectomes: 24-Channel 3T multi-array coil, MRI sequences and preprocessing by Joonas A. Autio, Matthew F. Glasser, Takayuki Ose, Chad J. Donahue, Matteo Bastiani, Masahiro Ohno, Yoshihiko Kawabata, Yuta Urushibata, Katsutoshi Murata, Kantaro Nishigori, Masataka Yamaguchi, Yuki Hori, Atsushi Yoshida, Yasuhiro Go, Timothy S. Coalson, Saad Jbabdi, Stamatios N. Sotiropoulos, Henry Kennedy, Stephen Smith, David C. Van Essen, Takuya Hayashi
Published in NeuroImage (2020-07-01)Get full text
Article -
10
CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study by Hendrik-Tobias Arkenau, Marta Gil-Martin, Fiona Thistlethwaite, Aung Naing, Karen A. Autio, Patrick A. Ott, Johanna Bendell, Patricia LoRusso, Valentina Boni, Alexander Spira, Javier Garcia-Corbacho, Mark Stroh, Elisabeth G.E. De Vries, Ferry A.L.M. Eskens, Nataliya Uboha, Manreet Randhawa, Greg Durm, Alison L. Hannah
Published in Journal for ImmunoTherapy of Cancer (2021-07-01)Get full text
Article -
11
First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-res... by Tian Zhang, Nicholas J Vogelzang, Daniel P Petrylak, Ravi A Madan, Karen A Autio, Ray Li, Helen Cho, Szu-Yu Tang, Celestia S Higano, Luke Nordquist, Leonard J Appleman, Xin-Hua Zhu, Hani Babiker, Sandip M Prasad, Michael T Schweizer, Stephane Billotte, Nora Cavazos, Orlaith Bogg, Kam Chan, Megan Kaneda, I-Ming Wang, Jenny Zheng, Robert Hollingsworth, Kenneth A Kern
Published in Journal for ImmunoTherapy of Cancer (2023-03-01)Get full text
Article -
12
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1) by Stephane Champiat, Aurélien Marabelle, Anna Spreafico, Mehmet Altan, Todd M Bauer, Osama Rahma, Karen A Autio, Neeta Somaiah, Meredith McKean, Aaron R Hansen, Jan H M Schellens, Willeke Ros, F Stephen Hodi, Jeffrey S Weber, John V Heymach, Herbert Struemper, Sandrine Aspeslagh, Daniel C Cho, Jennifer K Litton, Axel Hoos, Vincent K Lam, Emmett V Schmidt, Sophie Postel-Vinay, Frans L Opdam, Elaine M Paul, Christoph M Ahlers, Helen Zhou, Shelby A Gorman, Maura Watmuff, Kaitlin M Yablonski, Niranjan Yanamandra, Michael J Chisamore
Published in Journal for ImmunoTherapy of Cancer (2023-03-01)Get full text
Article
